Two other genes have been reported to be hypermethylated in 20% to 50% of PanNETs, namely CDKN2A and MGMT. The first encodes p16, a tumor suppressor that is frequently inactivated in cancer by copy loss, hypermethylation, or mutation (212). The gene discussed is CDKN2A; the disease is neoplasm.